Genmab — November 2020

[bibob]

https://beta.firstwordpharma.com/story/5156481?t=eyJhbGciOiJBMjU2S1ciLCJlbmMiOiJBMjU2Q0JDLUhTNTEyIiwiemlwIjoiREVGIn0.gmuRo1KW9QgxjKWgjadFiBL5ruQ3OqKis5bfxRjURZQyIZpnDq4ptViVrjSBjALev7Vs0MqhfxHxHp6nVIytuOuWtBoFi-7K.9TaTpmNJc2bZSWdsJaa8Ew.i9874vuvH5jURWJIG3tpXc_eMTAtxlRVfjM7F_pcU3bw0ITNdI8C0l--fenNpk1ooD0XjMaEbuIRJQAqDUW1DQwb5OIlc7CwMaPQa0RQ5-9ZYqyA6AxR98icA-zqnHoZ_qxidX7w0bZLQ7DcWhe3qvCpLJYR_5SN6GGAotVtG8s7BBphlRtedLyUy8oyE8wQ.UO35WwwKzdnw6yEcyu_sn4VkB0JvKI1em8IspXSWwBE&nle=8172&nlc=65

[GeorgeBest]

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Genmab (NASDAQ:GMAB) A/S on Thursday, setting a price target of $45

[GeorgeBest]

ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease https://ceo.ca/@newswire/immunoprecise-and-genmab-enter-into-a-technology-partnership

[E_L]

bit of a vague press release. Wondering if it has anything to do with this -27/9 07:54
af E L
I noted Genmab is looking for an Infectious Diseases Scientist and that there is something called "Genmab Infectious Disease initiative" (link)

[deleted-user]

@E L the link is broken

[deleted-user]

And by the way you soon need a 3rd hand when counting GEN1046 expansion

[Sukkeralf]

I think so E L

[E_L]

@LLI at the time it linked to an open job
postion Genmab had. The position is not there anymore (so either filled or pulled)

[deleted-user]

Thx

[peter12]

Regarding ImmunoPrecise couldn't it be one of the CV19 collaborations Jan mentioned in the FT chat ? They live together in the Utrecht science park

[E_L]

AbbVie "So, Genmab, as an example, that filled the gap in hematological oncology that we had. And we wanted an important asset that could cover more areas of hem/onc to continue to drive our leadership position. So, we strategically went out and looked for a CD3xCD20." https://seekingalpha.com/article/4390402-abbvie-inc-abbv-presents-wolfe-research-healthcare-conference-transcript

[Helge_LarsenPI-redaktør]

God morgen.

[Helge_LarsenPI-redaktør]

USA Luk: Dow Jones 0,2 prosent
S&P 500 opp 0,4 prosent
Nasdaq Composite 0,9 prosent

[transalp]

Go morgen..

[Helge_LarsenPI-redaktør]

Fredagens aviser med Danske Bank, Mærsk og Vestas: https://www.proinvestor.com/investornyt/669779/fredagens-aviser-med-danske-bank-maersk-og-vestas

[E_L]

https://ascopost.com/issues/november-25-2020-supplement-hematologic-oncology-almanac/bispecific-antibodies-poised-to-impact-treatment-of-lymphoma-and-other-blood-cancers/ Bispecific Antibodies Poised to Impact Treatment of Lymphoma and Other Blood Cancers

[Helge_LarsenPI-redaktør]

Aktier/tendens: Flad åbning i sigte med fokus på Maersk Drillinghttps://www.proinvestor.com/investornyt/669792/aktier-tendens-flad-abning-i-sigte-med-fokus-pa-maersk-drilling

[AaBforever]

Spændende hvornår vi begynder marchen mod 3000...pt. et skridt frem...et tilbage.

[StockBull]

Yes - helt som forventet https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/88742_2528.JPG

[Vitus]

Nej, man kan ikke lige sige at Genmab er flad i åbning...har faktisk skuffet noget de seneste måneder....